1. Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer. (23rd August 2018) Authors: Basho, Reva K.; Yam, Clinton; Gilcrease, Michael; Murthy, Rashmi K.; Helgason, Thorunn; Karp, Daniel D.; Meric‐Bernstam, Funda; Hess, Kenneth R.; Valero, Vicente; Albarracin, Constance; Litton, Jennifer K.; Chavez‐MacGregor, Mariana; Hong, David; Kurzrock, Razelle; Hortobagyi, Gabriel N.; Janku, ... Journal: Oncologist Issue: Volume 23:Number 11(2018) Page Start: 1300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of 122 advanced‐stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies. Issue 2 (19th October 2015) Authors: Al‐Rohil, Rami N.; Tarasen, Ashley J.; Carlson, J. Andrew; Wang, Kai; Johnson, Adrienne; Yelensky, Roman; Lipson, Doron; Elvin, Julia A.; Vergilio, Jo‐Anne; Ali, Siraj M.; Suh, James; Miller, Vincent A.; Stephens, Philip J.; Ganesan, Prasanth; Janku, Filip; Karp, Daniel D.; Subbiah, Vivek; Mihm, ... Journal: Cancer Issue: Volume 122:Issue 2(2016) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. Issue 9 (20th March 2023) Authors: Fu, Siqing; Yao, Shuyang; Yuan, Yuan; Previs, Rebecca A.; Elias, Anthony D.; Carvajal, Richard D.; George, Thomas J.; Yuan, Ying; Yu, Lihou; Westin, Shannon N.; Xing, Yan; Dumbrava, Ecaterina E.; Karp, Daniel D.; Piha-Paul, Sarina A.; Tsimberidou, Apostolia M.; Ahnert, Jordi Rodon; Takebe, Naoko;... Journal: Journal of clinical oncology Issue: Volume 41:Issue 9(2023) Page Start: 1725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Overview of Ocular Side Effects of Selinexor. (8th April 2021) Authors: Al-Zubidi, Nagham; Gombos, Dan S.; Hong, David S.; Subbiah, Vivek; Fu, Siqing; Ahnert, Jordi Rodon; Piha-Paul, Sarina A.; Tsimberidou, Apostolia M.; Karp, Daniel D.; Bernstam, Funda Meric; Naing, Aung Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Overview of Ocular Side Effects of Selinexor. (8th April 2021) Authors: Al‐Zubidi, Nagham; Gombos, Dan S.; Hong, David S.; Subbiah, Vivek; Fu, Siqing; Ahnert, Jordi Rodon; Piha‐Paul, Sarina A.; Tsimberidou, Apostolia M.; Karp, Daniel D.; Bernstam, Funda Meric; Naing, Aung Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials. (21st April 2021) Authors: Huey, Ryan W.; George, Goldy C.; Phillips, Penny; White, Revenda; Fu, Siqing; Janku, Filip; Karp, Daniel D.; Naing, Aung; Piha-Paul, Sarina; Subbiah, Vivek; Tsimberidou, Apostolia M.; Pant, Shubham; Yap, Timothy A.; Rodon, Jordi; Meric-Bernstam, Funda; Shih, Ya-Chen Tina; Hong, David S. Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient‐Reported Out‐of‐Pocket Costs and Financial Toxicity During Early‐Phase Oncology Clinical Trials. (21st April 2021) Authors: Huey, Ryan W.; George, Goldy C.; Phillips, Penny; White, Revenda; Fu, Siqing; Janku, Filip; Karp, Daniel D.; Naing, Aung; Piha‐Paul, Sarina; Subbiah, Vivek; Tsimberidou, Apostolia M.; Pant, Shubham; Yap, Timothy A.; Rodon, Jordi; Meric‐Bernstam, Funda; Shih, Ya‐Chen Tina; Hong, David S. Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies. Issue 3 (1st November 2018) Authors: Bhatty, Minny; Kato, Shumei; Piha‐Paul, Sarina A.; Naing, Aung; Subbiah, Vivek; Huang, Helen J.; Karp, Daniel D.; Tsimberidou, Apostolia M.; Zinner, Ralph G.; Hwu, Wen‐Jen; Javle, Milind; Patel, Sapna P.; Hu, Mimi I.; Varadhachary, Gauri R.; Conley, Anthony P.; Ramzanali, Nishma M.; Holley, Veron... Journal: Cancer Issue: Volume 125:Issue 3(2019) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours. (July 2022) Authors: Karp, Daniel D.; Camidge, D. Ross; Infante, Jeffery R.; Ames, Tyler D.; Price, Matthew R.; Jimeno, José; Bryce, Alan H. Journal: EClinicalMedicine Issue: Volume 49(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. Issue 1 (18th September 2019) Authors: Habra, Mouhammed Amir; Stephen, Bettzy; Campbell, Matthew; Hess, Kenneth; Tapia, Coya; Xu, Mingxuan; Rodon Ahnert, Jordi; Jimenez, Camilo; Lee, Jeffrey E.; Perrier, Nancy D.; Boraddus, Russell R.; Pant, Shubham; Subbiah, Vivek; Hong, David S.; Zarifa, Abdulrazzak; Fu, Siqing; Karp, Daniel D.; Mer... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗